
By: Rupprecht Podszun (D’Kart)
The Düsseldorf Higher Regional Court on Wednesday added a new twist to the Bundeskartellamt vs. Facebook saga: The case is going to Luxembourg to the European Court of Justice. Meanwhile, as of today, 24 March 2021, it remains open whether the Bundeskartellamt will have Facebook’s implementation plan submitted to it in the meantime. Rupprecht Podszun was at the hearing in the Düsseldorf Higher Regional Court for D’Kart.
As I stumbled out of the Higher Regional Court, out into the open, the sun was shining, I briefly took off my mask for a breath of fresh air, the Rhine was rolling with some momentum towards the North Sea – I met a well-known Düsseldorf antitrust lawyer whom I had not seen in the courtroom. Put the mask back on. Oh, he was with the beer cartel. True, that was running in parallel to the most exciting, most spectacular, most important antitrust case of the last few years, decades. (And if you forget about the beer cartel, which is quite juicy, that’s saying something).
The lawyer asked briefly how it went before he had to rush on and I said: The Facebook case is going to the ECJ. The expression on his face was priceless. It virtually summed up everything that had unfolded in terms of emotionality, irritation, enormous intellectual effort, theatricality and, ultimately, perplexity over several hours in Room A01 in the basement of the Düsseldorf Oberlandesgericht (OLG), the Higher Regional Court….
Featured News
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas